Andrew Firlik

Andrew Firlik

Signal active

General Partner

Bio

Dr. Firlik’s career spans neurosurgery, entrepreneurship, and venture capital. He joined Foundation Medical Partners to concentrate on medical device and biopharmaceutical investments.

Prior to Foundation, he was a venture partner at Sprout Group and Managing Director of its healthcare technology spinout, New Leaf Venture Partners.

Previously, he was a principal at Canaan Partners. Dr. Firlik has led numerous venture capital investments and has served as a founder, founding investor, or director of many early stage companies that have grown to become successful market leaders.

Dr. Firlik was a founder and an inventor of the core technology platform of Northstar Neuroscience, a medical device company that pioneered a novel approach to neuromodulation for the treatment of stroke and other disorders. Northstar went public in an IPO in 2006 (NASDAQ: NSTR) and was subsequently acquired by St. Jude Medical.

He recently served as the Chairman of Intelect Medical (acquired by Boston Scientific, NYSE: BSX), a neuromodulation company, and recently served as Chairman of NovaVision, a medical therapeutics firm focusing on neuroplasticity for visual disorders.

His current or recent board seats include BridgePoint Medical, Clear Catheter Systems, Explorys,NeuroVista, SetPoint Medical, Spine Wave, Vertos Medical, and Visiogen (acquired by Abbott, NYSE: ABT).

Dr. Firlik is a member of the Industrial Advisory Board of the Cleveland Clinic Innovations Center. He recently served as a member of the Administrative Board of the Cornell University Council and Chairman of its Technology Transfer Committee and also the Cornell University Biomedical Engineering Advisory Council and the Life Sciences Advisory Board.

Dr. Firlik spent 12 years in the healthcare profession during his medical training and practice as a neurological surgeon. He has published more than 50 articles in the medical literature, written chapters for several medical textbooks, and is the co-editor of a book about cerebrovascular surgery. His scientific work has been presented at many international conferences. He has been an inventor of numerous issued patents.

He studied biology at Cornell University and Oxford University, received his MBA from the University of Pittsburgh, and his MD from Cornell University Medical College. As a board certified neurosurgeon, Dr. Firlik most recently served as Clinical Assistant Professor of Neurosurgery at the New York University School of Medicine.

Location

Norwalk, Connecticut, United States, North America

Social

Primary Organization

Jazz Venture Partners

Jazz Venture Partners

Founded

2015

Investment

81

Lead investment

35

Exits

10

Employees

11-50

Industry

Financial Services, Venture Capital, Financial Exchanges

Jobs history

4

Zus Health

Board of Directors

2023 - Current

Thrive Global

Board Member

Invalid date - Current

Arrive Health

Board Member

Invalid date - Current

Managing Partner

Invalid date - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Andrew Firlik is the General Partner at Jazz Venture Partners, based in United States, North America. With a background in Financial Services, Andrew Firlik has a rich history of leadership and innovation. Andrew Firlik studied MD unknown @ Cornell University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

10

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Sep 09, 2021
Blue Note Therapeutics Blue Note Therapeutics
Series A - Blue Note Therapeutics
Blue Note Therapeutics Jazz Venture Partners
5.2M
Oct 28, 2021
Magnus Medical Magnus Medical
Series A - Magnus Medical
Magnus Medical Jazz Venture Partners
25.0M
Dec 20, 2021
Yumi Yumi
Series B - Yumi
Yumi Jazz Venture Partners
67.0M
Mar 16, 2023
Zus Health Zus Health
Series A - Zus Health
Zus Health Jazz Venture Partners
40.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.